Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zomedica Pharmaceuticals Corp (NY: ZOM )

0.1312 UNCHANGED
Streaming Delayed Price Updated: 8:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zomedica Pharmaceuticals Corp

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Zomedica Continues to Execute Poorly
It's been 3.5 months since Zomedica launched Truforma. Unfortunately, due to its poor execution, ZOM stock continues to suffer. 
Via InvestorPlace
Zomedica’s Business Model Is Good, But It’s Still Overpriced
Giving away razors and charging for the blades is often a good idea, but ZOM stock still isn't a good value until it drops closer to 40 cents. 
Via InvestorPlace
The Time to Buy Zomedica Stock May Be Near
After its post-meme collapse, pet healthcare play ZOM stock is still pricey. Wait for it to inch closer to a more optimal entry point. 
Via InvestorPlace
Zomedica Needs to Start Delivering Tangible Results
Zomedica has an interesting story that could work out. However, the company's inability to execute is raising key concerns about ZOM stock. 
Via InvestorPlace
Risks Outweigh Rewards of a Move Into Zomedica Stock Right Now
ZOM stock needs to ramp up sales by a significant margin before investors can get excited about investing in it at this time 
Via InvestorPlace
ZOM Stock Is on the Move, but That Doesn’t Make It a Good Play Here
After months of declining, ZOM stock may have found a floor. The question is if that will hold. Set this one aside for the time being. 
Via InvestorPlace
63 Biggest Movers From Yesterday
Gainers Support.com, Inc. (NASDAQ: SPRT) shares surged 41.1% to settle at $19.70 on Thursday on abnormally high volume. TSR, Inc. (NASDAQ: TSRI) shares rose 28.1% to close at $11... 
Via Benzinga
Zomedica's Stock Approaches Important Level
Shares of Zomedica Corp. (NYSE: ZOM) are trading higher after the company released earnings. If the stock continues to rally, there's a chance it runs into sellers around... 
Via Benzinga
45 Stocks Moving In Thursday's Mid-Day Session
Gainers Blue Water Acquisition Corp. (NASDAQ: BLUW) shares climbed 57% to $16.41. Blue Water Acquisition is expected to hold a special meeting of its stockholders on Friday,... 
Via Benzinga
Why Zomedica Stock Is Zooming Higher Today
Investors appear to be bullish about the stock after a major investment bank disclosed earlier this week that it had bought shares of Zomedica. 
Via The Motley Fool
Topics Regulatory Compliance
Exposures Legal Regulatory
ZOM Stock: What Investors Are Saying About Meme Stock Favorite Zomedica as Shares Fly
Zomedica (ZOM) stock is soaring higher on Thursday as the stock continues a rally that's been taking place over the last couple of days. 
Via InvestorPlace
22 Stocks Moving in Thursday's Pre-Market Session
Gainers Good Works Acquisition Corp. (NASDAQ: GWAC) rose 29.8% to $13.01 in pre-market trading. Good Works Acquisition and Cipher Mining reported shareholder approval of business... 
Via Benzinga
1 Number That Might Send Investors Running From Zomedica's Stock
A lack of sales growth and rising expenses could send this struggling stock even lower. 
Via The Motley Fool
ZOM Stock: Can the Latest Meme Stocks Surge Take Zomedica to $1?
Today, investors in Zomedica are seeing a lot of green as a recent meme-stock surge takes ZOM stock materially higher. 
Via InvestorPlace
The Second Half of 2021 Should Be Much Easier for Zomedica Investors
So far, it hasn't been easy to stay the course with ZOM stock. Q3 and Q4 developments, however, should lift the shareholders' spirits. 
Via InvestorPlace
Why Zomedica Stock Has Lost Its Luster
There are a few glaring reasons behind the once high-flying stock's decline. 
Via The Motley Fool
77 Biggest Movers From Yesterday
Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares surged 65.4% to close at $2.10 on Thursday after the company announced it is expanding its blockchain business to... 
Via Benzinga
54 Stocks Moving In Thursday's Mid-Day Session
Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) jumped 64.2% to $2.0850 after the company announced it is expanding its blockchain business to engage in cryptocurrency... 
Via Benzinga
What's Happening With Zomedica's Stock Today?
Zomedica Corp (NASDAQ: ZOM) shares are trading lower by 13.6% at $0.49 Thursday morning after the company reported second-quarter earnings results. Zomedica reported... 
Via Benzinga
30 Stocks Moving in Thursday's Pre-Market Session
Gainers Conifer Holdings, Inc. (NASDAQ: CNFR) shares rose 40.9% to $4.00 in pre-market trading after the company reported better-than-expected Q2 sales. The ExOne Company (NASDAQ... 
Via Benzinga
Zomedica Is an Excellent Spec Play After Falling
ZOM stock is trading at a discount, which means this is the perfect time for investors to trade this one for short-term profits. 
Via InvestorPlace
Time Is Passing Too Slowly For Zomedica Speculators
Zomedica speculators are being told to be patient, but there's a time cost to money and some will likely let ZOM stock go soon. 
Via InvestorPlace
There’s Little That’s Attractive About Once-Hot Zomedica Stock… for Now
Zomedica has become a slow-motion train wreck. ZOM stock investors should look for alternatives to the animal diagnostics firm. 
Via InvestorPlace
Zomedica Stock Might Not Appeal To Millennials as Much as Some Hope
While young people own pets, the question for ZOM stock is whether they will truly care for them. 
Via InvestorPlace
Avoid Zomedica Stock As It’s Bogged Down By Too Many Red Flags
Resignation of Zomedica's President and CMO, and the CEO are red flags. Wait to buy ZOM stock until 30 cents for a margin of safety. 
Via InvestorPlace
Zomedica Is Still Working Out How to Sell Truforma. Can Investors Afford to Wait?
Zomedica came public too soon, but it does have enough cash to see a finish line. The question is, can ZOM stock investors afford to wait? 
Via InvestorPlace
Ignore Zomedica’s Recent Struggles. The Road Ahead Remains Bright.
ZOM stock has come under price pressure recently, but the outlook is bright as Zomedica plots a road map to success. 
Via InvestorPlace
Speculative Investors Are Crazy Not to Buy Zomedica at Its Current Prices
Under 75 cents, ZOM stock is a penny stock worth betting on 
Via InvestorPlace
Wait for Zomedica to Give Up More of its Meme Stock Gains
It's not there yet, but if ZOM stock pulls back another 50% or so, the risk/return proposition will be more in your favor. 
Via InvestorPlace
Zomedica Stock Still Has a Rocky Few Months Left Ahead of It
ZOM stock is rife with massive potential. But it's the same potential that has gone unfulfilled for the past few months. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.